SREBP-1c is activated by overnutrition, obesity, inflammation, oxidative stress, endoplasmic reticulum (ER) stress, etc. Our findings demonstrated that farnesoid X receptor (FXR), a member of the nuclear receptor superfamily, could negatively regulate de novo lipogenesis by counteraction against SREBP-1c. The gene discussed is NR1H4; the disease is obesity disorder.